This Week in Science

In Science Translational Medicine this week, a Harvard University-led team reports a new test for pancreatic ductal adenocarcinoma (PDAC) that performs better than currently available diagnostics. The researchers used a multiplexed plasmonic assay to analyze circulating tumor-derived extracellular vesicles and identify a signature of five protein biomarkers that could be used to diagnose the disease with 86 percent sensitivity and 81 percent specificity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.